Clinical Trial Update: Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hepatocellular Carcinoma

View source ↗

Summary

A clinical trial update describes an intelligence system intended to predict response and outcomes to atezolizumab-bevacizumab in unresectable hepatocellular ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: First Affiliated Hospital of Wenzhou Medical University | Conditions: HCC - Hepatocellular Carcinoma, Atezolizumab and Bevacizumab in Hepatocellular Carcinoma | Status: NOT_YET_RECRUITING